Magnasense logotype


Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website,, launched on 9 July 2024, with redirects from

AegirBio publish video presentation by CEO Marco Witteveen

AegirBio AB has published a video presentation by CEO Mr. Witteveen on the company´s official website ( In the presentation Mr. Witteveen addresses transformative structural changes and offers a forward-looking glimpse into the company's strategic trajectory

Mr. Witteveen is shedding light on impactful changes to bolster AegirBio's market position. The presentation provides an understanding of AegirBio's customer-centric, innovation-driven future.

"We're at an exciting juncture in AegirBio's journey," remarked Mr. Witteveen. "The enhancements lay the foundation for a more business driven organization. This presentation is a testament to our commitment to transparency and a preview of the dynamic future we're building together."

About Aegirbio

AegirBio is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, AegirBio was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Aegirbio's website

The company's Certified Adviser is Eminova Fondkomission AB | 08-684 211 00 |

Related link: